Cargando…
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
The B-cell CLL/lymphoma 2 (BCL2) gene family encodes pro- and anti-apoptotic proteins that are critical regulators of programmed cell death. Higher levels of BCL2 expression in breast tumours have been shown to be an independent prognostic factor for improved survival from breast cancer. The promote...
Autores principales: | Searle, Claire J, Brock, Ian W, Cross, Simon S, Balasubramanian, Sabapathy P, Reed, Malcolm WR, Cox, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725909/ https://www.ncbi.nlm.nih.gov/pubmed/23961365 http://dx.doi.org/10.1186/2193-1801-1-38 |
Ejemplares similares
-
Effect of Bcl-2 rs956572 Polymorphism on Age-Related Gray Matter Volume Changes
por: Liu, Mu-En, et al.
Publicado: (2013) -
Association of BCL2 polymorphisms and the
IL19 single nucleotide polymorphism rs2243188 with systemic
lupus erythematosus
por: Wang, Weijie, et al.
Publicado: (2021) -
Praf2 Is a Novel Bcl-xL/Bcl-2 Interacting Protein with the Ability to Modulate Survival of Cancer Cells
por: Vento, Maria Teresa, et al.
Publicado: (2010) -
Bcl-B: an “unknown” protein of the Bcl-2 family
por: Pervushin, N. V., et al.
Publicado: (2023) -
Polymorphisms of the BCL2 gene associated with susceptibility to tuberculosis
por: He, Juan, et al.
Publicado: (2022)